Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Survival of Hodgkin Lymphoma Patients Treated with Novel Immunotherapies after Autologous Stem Cell Transplantation Failure: A Retrospective Analysis of the Italian Lymphoma Foundation (FIL)

Maura Nicolosi, Valentina Bozzoli, Sabino Ciavarella, Cattina Federica, Gloria Margiotta Casaluci, Ombretta Annibali, Alessia Castellino, Francesco Rotondo, Luigi Petrucci, Federica Cocito, Sofya Kovalchuk, Erika Meli, Natalia Cenfra, Sara Bigliardi, Angelo Fama, Stefano Volpetti, Barbara Botto, Benedetto Bruno, Francesco Zaja

Blood (2023) 142 (Supplement 1): 6219.

https://doi.org/10.1182/blood-2023-187563

Published: 2023

Journal Articles

Radiotherapy Consolidation Reduces Risk of Relapse in Diffuse Large B-Cell Lymphoma Patients with Bulky Disease in Complete Response after Frontline Immunochemotherapy: Results from a Retrospective Single Center Study

Corrado Benevolo Savelli, Mattia Novo, Francesco Vassallo, Andrea Evangelista, Matteo Bisio, Luca Legato, Veronica Peri, Michele Clerico, Mario Levis, Sara Bartoncini, Chiara Cavallin, Maura Nicolosi, Carola Boccomini, Lorella Orsucci, Federica Cavallo, Benedetto Bruno, Roberto Freilone, Umberto Ricardi, Barbara Botto

Blood (2023) 142 (Supplement 1): 4484.

https://doi.org/10.1182/blood-2023-184510

Published: 2023

Journal Articles

Cytogenetic Clonal Evolution in Myeloproliferative Neoplasms: Contexts and Prognostic Impact Among 650 Patients with Serial Bone Marrow Biopsies

Maura Nicolosi, MD, Domenico Penna, MD, Mythri Mudireddy, MBBS, Natasha Szuber, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Rhett P. Ketterling, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 4291.

https://doi.org/10.1182/blood-2018-99-109714

Published: 2018

Journal Articles

20+ Years and Alive with Primary Myelofibrosis: Phenotypic Signature of Very Long-Lived Patients

Domenico Penna, MD, Maura Nicolosi, MD, Mythri Mudireddy, MBBS, Natasha Szuber, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 4301.

https://doi.org/10.1182/blood-2018-99-109718

Published: 2018

Journal Articles

Chronic Myeloid Leukemia Italian Multicenter Observational Study (CML-IT-MOS): Clinical Characteristics of Chronic Myeloid Leukemia (CML) Patients Treated in Real-Life between 2012 and 2016 in 66 Italian Hematology Centers of the Gimema Study Group

Blood (2018) 132 (Supplement 1): 45.

https://doi.org/10.1182/blood-2018-99-116648

Published: 2018

Journal Articles

Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia (MIPSS-ET) and Polycythemia Vera (MIPSS-PV)

Ayalew Tefferi, MD, Paola Guglielmelli, MD PhD, Terra L. Lasho, PhD, Giacomo Coltro, MD, Christy Finke, BS, Giuseppe Gaetano Loscocco, MD, Mythri Mudireddy, MBBS, Benedetta Sordi, MD, Natasha Szuber, MD, Giada Rotunno, PhD, Rangit Vallapureddy, MBBS, Annalisa Pacilli, PhD, Maura Nicolosi, MD, Domenico Penna, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Alessandro M. Vannucchi, MD

Blood (2018) 132 (Supplement 1): 578.

https://doi.org/10.1182/blood-2018-99-109715

Published: 2018

Journal Articles

Myeloproliferative Neoplasms in Young Patients: The Mayo Clinic Experience with 361 Cases Age 40 Years or Younger

Natasha Szuber, MD, Mythri Mudireddy, MBBS, Maura Nicolosi, MD, Domenico Penna, MD, Rangit Reddy Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3033.

https://doi.org/10.1182/blood-2018-99-117540

Published: 2018

Journal Articles

Serum Erythropoietin Levels in Essential Thrombocythemia: Phenotypic and Prognostic Correlates

Natasha Szuber, MD, Sravanthi Lavu, MBBS, Mythri Mudireddy, MBBS, Maura Nicolosi, MD, Domenico Penna, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3034.

https://doi.org/10.1182/blood-2018-99-109721

Published: 2018

Journal Articles

3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber, MD, Mythri Mudireddy, MBBS, Maura Nicolosi, MD, Domenico Penna, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Kebede H. Begna, MD, Michelle A. Elliott, MD, C. Christopher Hook, MD, Alexandra Wolanskyj, MD, Mrinal M. Patnaik, MD MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, Shireen Sirhan, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Lambert Busque, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3035.

https://doi.org/10.1182/blood-2018-99-109740

Published: 2018

Journal Articles

Mutations and Thrombosis in Essential Thrombocythemia and Polycythemia Vera: Mayo-Careggi Alliance Study

Paola Guglielmelli, MD PhD, Naseema Gangat, MBBS, Giacomo Coltro, MD, Terra L. Lasho, PhD, Giuseppe Gaetano Loscocco, MD, Christy Finke, BS, Benedetta Sordi, MD, Mythri Mudireddy, MBBS, Giada Rotunno, PhD, Natasha Szuber, MD, Annalisa Pacilli, PhD, Rangit Reddy Vallapureddy, MBBS, Maura Nicolosi, MD, Domenico Penna, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, Animesh Pardanani, MBBS, PhD, Alessandro M. Vannucchi, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3040.

https://doi.org/10.1182/blood-2018-99-110045

Published: 2018

Journal Articles

Risk Factors for Leukemic Transformation Among 1,306 Patients with Primary Myelofibrosis: Mutations Predict Early Events

Rangit Reddy Vallapureddy, MBBS, Mythri Mudireddy, MBBS, Natasha Szuber, MD, Domenico Penna, MD, Maura Nicolosi, MD, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, Kebede H. Begna, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2018-99-109895

Published: 2018

Journal Articles

Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients

Blood (2017) 130 (Supplement 1): 1639.

https://doi.org/10.1182/blood.V130.Suppl_1.1639.1639

Published: 2017

Journal Articles

Bone Marrow Reticulin Fibrosis in 579 Patients with Polycythemia Vera and Essential Thrombocythemia: Effect on Clinical Outcome

Giulia Benevolo, MD, Maura Nicolosi, Francesca Palandri, MD PhD, Laura Godio, MD, Andrea Evangelista, MSc, Elena Crisà, MBBS, MD, Elena Sabattini, MD, Barbara Nicolino, MD, Ludovica Riera, BSc, PhD, Michele Cavo, MD, Umberto Vitolo, MD

Blood (2016) 128 (22): 3130.

https://doi.org/10.1182/blood.V128.22.3130.3130

Published: 2016

Journal Articles

Myc and Bcl2 Overexpression and Traslocation Assessed By Immunohystochemistry (IHC) and FISH: Retrospective Analysis in a Series of De Novo DLBCL Homogeneously Treated with Rituximab-CHOP

Chiara Ciochetto, Maria Stella Scalzo, Barbara Botto, Alessia Castellino, Annalisa Chiappella, MD, Mattia Novo, Maura Nicolosi, Elisa Santambrogio, Federica Cavallo, MD, Paola Ghione, Andrea Evangelista, MSc, Giovannino Ciccone, MD PhD, Roberto Chiarle, MD, Domenico Novero, MD, Umberto Vitolo, MD

Blood (2016) 128 (22): 5305.

https://doi.org/10.1182/blood.V128.22.5305.5305

Published: 2016

Journal Articles

Risk Factors for Infections in Myelofibrosis: Role of Disease Status and Treatment. A Study on 507 Patients

Nicola Polverelli, MD, Massimo Breccia, MD, Giulia Benevolo, MD, Bruno Martino, MD, Alessia Tieghi, MD, Roberto Latagliata, MD, Lucia Catani, PhD, Maura Nicolosi, MD, Margherita Perricone, Marco Romano, Gioia Colafigli, Anna Campana, Francesco Merli, MD, Umberto Vitolo, Giuliana Alimena, MD, Giovanni Martinelli, Michele Cavo, MD, Nicola Vianelli, MD, Francesca Palandri, MD PhD

Blood (2015) 126 (23): 1606.

https://doi.org/10.1182/blood.V126.23.1606.1606

Published: 2015

Journal Articles

Impact of Age, Therapy and Molecular Profile in Myelofibrosis Patients. Analysis on 123 Patients from a Single Italian Haematological Center

Giulia Benevolo, MD, Eloise Beggiato, MD, Ludovica Riera, BSc, PhD, Andrea Evangelista, Anna Campana, Barbara Nicolino, MD, Maura Nicolosi, MD, Lucia Biale, MD, Dario Ferrero, MD, Umberto Vitolo

Blood (2015) 126 (23): 5188.

https://doi.org/10.1182/blood.V126.23.5188.5188

Published: 2015

Journal Articles

Prognostic Value of JAK2V617F, Calr and MPL Mutational Status on Outcome and Thrombotic Risk in a Retrospective Cohort of 138 Patients with Essential Thrombocythemia

Giulia Benevolo, MD, Ludovica Riera, PhD, Barbara Nicolino, MD, Andrea Evangelista, Eloise Beggiato, MD, Chiara Aguzzi, MD, Maura Nicolosi, MD, Chiara Frairia, MD, Umberto Vitolo, MD

Blood (2014) 124 (21): 5553.

https://doi.org/10.1182/blood.V124.21.5553.5553

Published: 2014

Journal Articles

Relapsed Or Refractory Aggressive Non Hodgkin B-Cell Lymphomas Treated With Lenalidomide With/Without Rituximab Or Steroids: A Single Center Restrospective Study

Alessia Castellino, Annalisa Chiappella, Paola Ghione, Manuela Ceccarelli, Giulia Benevolo, MD, Barbara Botto, Daniele Caracciolo, Chiara Ciochetto, Maura Nicolosi, Lorella Orsucci, Clara Pecoraro, Patrizia Pregno, Paola Riccomagno, Manuela Zanni, Marco Ladetto, Umberto Vitolo, MD

Blood (2013) 122 (21): 5119.

https://doi.org/10.1182/blood.V122.21.5119.5119

Published: 2013

Journal Articles

A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib

Dario Ferrero, Elena Crisà, Marco Cerrano, Mario Boccadoro, MD, Francesca Pirillo, Maura Nicolosi, Umberto Vitolo, Giovanna Rege Cambrin, Carmen Fava, MD, Giuseppe Saglio, MD, Monia Lunghi, Gioacchino Catania, MD, Alessandro Levis, MD, Patrizia Pregno

Blood (2012) 120 (21): 4446.

https://doi.org/10.1182/blood.V120.21.4446.4446

Published: 2012

Journal Articles

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Barbara Botto, Simone Ferrero, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Giorgio Limerutti, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Roberto Passera, Gianni Bisi, Umberto Vitolo

Blood (2012) 119 (9): 2066–2073.

https://doi.org/10.1182/blood-2011-06-359943

Published: 2012

NARROW

Survival of Hodgkin Lymphoma Patients Treated with Novel Immunotherapies after Autologous Stem Cell Transplantation Failure: A Retrospective Analysis of the Italian Lymphoma Foundation (FIL)

Radiotherapy Consolidation Reduces Risk of Relapse in Diffuse Large B-Cell Lymphoma Patients with Bulky Disease in Complete Response after Frontline Immunochemotherapy: Results from a Retrospective Single Center Study

Cytogenetic Clonal Evolution in Myeloproliferative Neoplasms: Contexts and Prognostic Impact Among 650 Patients with Serial Bone Marrow Biopsies

20+ Years and Alive with Primary Myelofibrosis: Phenotypic Signature of Very Long-Lived Patients

Chronic Myeloid Leukemia Italian Multicenter Observational Study (CML-IT-MOS): Clinical Characteristics of Chronic Myeloid Leukemia (CML) Patients Treated in Real-Life between 2012 and 2016 in 66 Italian Hematology Centers of the Gimema Study Group

Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia (MIPSS-ET) and Polycythemia Vera (MIPSS-PV)

Myeloproliferative Neoplasms in Young Patients: The Mayo Clinic Experience with 361 Cases Age 40 Years or Younger

Serum Erythropoietin Levels in Essential Thrombocythemia: Phenotypic and Prognostic Correlates

3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Mutations and Thrombosis in Essential Thrombocythemia and Polycythemia Vera: Mayo-Careggi Alliance Study

Risk Factors for Leukemic Transformation Among 1,306 Patients with Primary Myelofibrosis: Mutations Predict Early Events

Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients

Bone Marrow Reticulin Fibrosis in 579 Patients with Polycythemia Vera and Essential Thrombocythemia: Effect on Clinical Outcome

Myc and Bcl2 Overexpression and Traslocation Assessed By Immunohystochemistry (IHC) and FISH: Retrospective Analysis in a Series of De Novo DLBCL Homogeneously Treated with Rituximab-CHOP

Risk Factors for Infections in Myelofibrosis: Role of Disease Status and Treatment. A Study on 507 Patients

Impact of Age, Therapy and Molecular Profile in Myelofibrosis Patients. Analysis on 123 Patients from a Single Italian Haematological Center

Prognostic Value of JAK2V617F, Calr and MPL Mutational Status on Outcome and Thrombotic Risk in a Retrospective Cohort of 138 Patients with Essential Thrombocythemia

Relapsed Or Refractory Aggressive Non Hodgkin B-Cell Lymphomas Treated With Lenalidomide With/Without Rituximab Or Steroids: A Single Center Restrospective Study

A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only